Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | CA3 | P07451 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | F2 | P00734 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.48 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | VDR | P11473 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL30951756 | 0.94 | CA1 (0.50) | CA1CA2CA9CA12CA3 | |
| SCHEMBL14502467 | 0.90 | HTT (0.58) | CA1CA2CA9CA12CA3 | |
| SCHEMBL9180970 | 0.87 | ALDH1A1 (0.40) | CA1CA2CA9CA12CA3 | |
| SCHEMBL27449107 | 0.85 | GLA (0.47) | CA1CA2CA9CA12CA3 | |
| SCHEMBL12732183 | 0.80 | CA2 (0.52) | CA1CA2CA9CA12SMN1; SMN2 | |
| SCHEMBL7186972 | 0.80 | GAA (0.59) | CA1CA2CA9CA12CA3 | |
| SCHEMBL6490 | 0.80 | GAA (0.59) | CA1CA2CA9CA12CA3 | |
| Water SCHEMBL3352692 | 0.78 | GAA (0.56) | CA1CA2CA9CA12CA3 | |
| SCHEMBL9901122 | 0.78 | GAA (0.56) | CA1CA2CA9CA12CA3 | |
| SCHEMBL27524 | 0.78 | GAA (0.56) | CA1CA2CA9CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630421-A1 | SYNTHESIS OF SULFOXIMINE COMPOUNDS HAVING A STEREOGENIC SULFUR ATOM | Syngenta Crop Protection AG (CH) | 2025-10-15 | — | — | EP | claimed |
| CN-116284010-B | Tetranitropyrazolotetrazine Synthesis method of energetic material | 南京理工大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119638627-A | Bipyrazole energetic compound and preparation method thereof | 西北大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119143684-A | High-energy-density energetic compound and preparation method thereof | 南京理工大学 | 2024-12-17 | — | — | CN | claimed |
| CN-115322153-B | Bipyrazole energetic compound or energetic salt and preparation method thereof | 北京理工大学 | 2024-06-14 | — | — | CN | claimed |
| WO-2024121335-A1 | SYNTHESIS OF SULFOXIMINE COMPOUNDS HAVING A STEREOGENIC SULFUR ATOM | SYNGENTA CROP PROTECTION AG (CH) | 2024-06-13 | — | — | WO | claimed |
| CN-116925609-A | Preparation formula of water-based automotive finishing paint | 东北林业大学 | 2023-10-24 | — | — | CN | claimed |
| CN-116284010-A | Synthesis method of tetranitropyrazolotetrazine energetic material | 南京理工大学 | 2023-06-23 | — | — | CN | claimed |
| WO-2023070957-A1 | ANTI-REFLECTIVE COATING COMPOSITION AND CROSSLINKABLE POLYMER | 嘉庚创新实验室 | 2023-05-04 | — | — | WO | claimed |
| CN-115651462-A | Preparation formula of water-based automobile aluminum powder paint | 东北林业大学 | 2023-01-31 | — | — | CN | claimed |
| EP-2318402-B1 | Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as CCR3 receptor ligands | SANOFI SA (FR) | 2014-04-30 | — | — | EP | claimed |
| US-8420636-B2 | Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as CCR3 receptor ligands | SANOFI (FR) | 2013-04-16 | — | — | US | claimed |
| JP-2011529482-A | — | — | 2011-12-08 | — | — | JP | claimed |
| US-20110144104-A1 | PYRROLIDINYL-ALKYL-AMIDE DERIVATIVES, THEIR PREPARATION, AND THEIR THERAPEUTIC APPLICATION AS CCR3 RECEPTOR LIGANDS | SANOFI-AVENTIS (FR) | 2011-06-16 | — | — | US | claimed |
| EP-2318402-A2 | PYRROLIDINYL-ALKYL-AMIDE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION AS CCR3 RECEPTOR LIGANDS | Sanofi-aventis (FR) | 2011-05-11 | — | — | EP | claimed |
| WO-2010013078-A2 | PYRROLIDINYL-ALKYL-AMIDE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION AS CCR3 RECEPTOR LIGANDS | SANOFI-AVENTIS (FR) | 2010-02-04 | — | — | WO | claimed |
| EP-2097370-A2 | COMPOUNDS AND METHODS FOR AMINO-ALKYLENEDIOL SYNTHESIS | F. Hoffmann-Roche AG (CH) | 2009-09-09 | — | — | EP | claimed |
| US-20080280963-A1 | New amino-alkyl-amide derivatives as CCR3 receptor ligands | SANOFI-AVENTIS (FR) | 2008-11-13 | — | — | US | claimed |
| WO-2008077799-A2 | COMPOUNDS AND METHODS FOR AMINO-ALKYLENEDIOL SYNTHESIS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-07-03 | — | — | WO | claimed |
| US-20080154063-A1 | Compounds and methods for amino-alkylenediol synthesis | ROCHE PALO ALTO LLC | 2008-06-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080154063-A1 | Compounds and methods for amino-alkylenediol synthesis | DAO, MSMO1, STS | CA1 940/4885CA2 1300/4885CA9 1433/4885 |
| US-20080280963-A1 | New amino-alkyl-amide derivatives as CCR3 receptor ligands | CCR3, CCR1, CCR4 | CA1 3024/4885CA2 3234/4885CA9 2409/4885 |
| US-20110144104-A1 | PYRROLIDINYL-ALKYL-AMIDE DERIVATIVES, THEIR PREPARATION, AND THEIR THERAPEUTIC APPLICATION AS CCR3 RECEPTOR LIGANDS | CCR3, CCR1, CCR4 | CA1 3511/4885CA2 2966/4885CA9 2482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.